| Literature DB >> 18345029 |
D M Langenau1, M D Keefe, N Y Storer, C A Jette, A C H Smith, C J Ceol, C Bourque, A T Look, L I Zon.
Abstract
The zebrafish has emerged as a powerful genetic model of cancer, but has been limited by the use of stable transgenic approaches to induce disease. Here, a co-injection strategy is described that capitalizes on both the numbers of embryos that can be microinjected and the ability of transgenes to segregate together and exert synergistic effects in forming tumors. Using this mosaic transgenic approach, gene pathways involved in tumor initiation and radiation sensitivity have been identified.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18345029 PMCID: PMC2680704 DOI: 10.1038/onc.2008.56
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867